	Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy. Cureus Bivolarski I, Dimitrov M, Dechev H. PMID: 42535191 [PubMed]
	Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management. Front Oncol Bakshi G, Lyon A, Joshi A, Agarwala V, Raghunath SK, Addla SK, Taneja R, Mandani A, Kashyapi B, Bhargava S, Sharma R, Agrawal V, Nagar R, Srivathsan R, Patel K, Patel R, Shah H, Lai A, Mukherjee A, Pandey S, Rajput A. PMID: 42534891 [PubMed]
	AI-driven precision diagnosis and treatment of prostate cancer: a narrative review. Front Oncol Chu T, Zhang Y, Du J, Mierxiati A. PMID: 42534734 [PubMed]
	Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review). Mol Clin Oncol N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S. PMID: 42534213 [PubMed]
	[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer. Int J Urol Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N. PMID: 42533777 [PubMed - indexed for MEDLINE]
	Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population. Int J Urol Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group. PMID: 42533764 [PubMed - indexed for MEDLINE]
	Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer. Geriatr Gerontol Int Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K. PMID: 42533722 [PubMed - indexed for MEDLINE]
	Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT. Mol Imaging Biol Zirakchian Zadeh M. PMID: 42533239 [PubMed - as supplied by publisher]
	Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial. J Nucl Med Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J. PMID: 42532646 [PubMed - as supplied by publisher]
	Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort. BMJ Open Zhou X, He Y, Jin Y, Peng Z, Zeng B, Zhang Z, Wu Y, Wei C, Mo Z, Cheng J, Chen Y, Wang F, Lu G, Tao K, Yang Z, Wu Y, Zhang W, Zhuang C, Guo W, Li G, Liu Y, Huang Y, Gao R, Zhan Y, Zou X, Yang L, Wei Q, Wei X, Qiu S. PMID: 42532568 [PubMed - indexed for MEDLINE]
	[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment]. Aktuelle Urol Paffenholz P, Heidenreich A, Weiten R. PMID: 42532107 [PubMed - as supplied by publisher]
	Can prostate cancer be diagnosed with near certainty on MRI? Eur J Radiol Cummings C, Allen C, Dickinson L, Pendse D, Emberton M, Giganti F, Moore C, Woernle A, Freeman A, Haider A, Kirkham A. PMID: 42531699 [PubMed - as supplied by publisher]
	Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States. JCO Oncol Pract Zhang G, Fann J, Castro DV, Shah KU, Li X, Abreu de Goes V, Jaime-Casas S, Mercier B, Li YJ, Agarwal R, Dickter S, Dukkipati A, Goud J, Lau L, Lau LM, Lee J, Shah K, Simon R, Swarat E, Zugman M, Moradi A, Hsu J, Dizman N, Nguyen C, Chehrazi-Raffle A, Barragan-Carrillo R, Pal SK. PMID: 42531525 [PubMed - as supplied by publisher]
	Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis. Can Urol Assoc J Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O. PMID: 42531453 [PubMed - as supplied by publisher]
	Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder. Can Urol Assoc J Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, Aghdam N, Olumi AF, Chang P, Wagner A, Gershman B. PMID: 42531446 [PubMed - as supplied by publisher]
	Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial. Clin Cancer Res Zhao SG, Holmberg E, Lundstedt D, Killander F, Niméus E, Sharifi M, Sjöström M, Karlsson P. PMID: 42531378 [PubMed - as supplied by publisher]
	Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially? Am J Mens Health Tian S, Li H, Jiang Y, Wang C, Liu S, Wu F, Ning H. PMID: 42531155 [PubMed - indexed for MEDLINE]
	Patient-Provider Communication and Treatment Decision-Making among Latino Men with Prostate Cancer: A Qualitative Study. J Racial Ethn Health Disparities Rodriguez VE, Mendoza-Aguayo B, Rodriguez J, Ramirez CM, Soto D, Unger JB, Abreu AL, Ariani R, Baezconde-Garbanati L, Ballas L, Stern MC. PMID: 42530811 [PubMed - as supplied by publisher]
	Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches. Cell Biol Int Sayed U, Basheer NM, H M, Nayak PP, Shankhyan A, Eshmetov R, Sadikova S, Ataullaev Z. PMID: 42529891 [PubMed - indexed for MEDLINE]
	Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics. Front Immunol Zhang Z, He L, Chen B, Zhang H. PMID: 42529102 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180421

Page 1 of 9022



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy